MOVANTIK (AstraZeneca Pharmaceuticals LP)


Welcome to the PulseAid listing for the MOVANTIK drug offered from AstraZeneca Pharmaceuticals LP. This Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AstraZeneca Pharmaceuticals LP
NON-PROPRIETARY NAME: naloxegol oxalate
SUBSTANCE NAME: NALOXEGOL OXALATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Opioid Antagonist [EPC],Opioid Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-03-06
END MARKETING DATE: 0000-00-00


MOVANTIK HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMOVANTIK from AstraZeneca Pharmaceuticals LP
LABELER NAME: AstraZeneca Pharmaceuticals LP
DEA SCHEDULE:
ACTIVE STRENGTH: 12.5(mg/1)
START MARKETING DATE: 2015-03-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0310-1969_8469faae-0022-45a8-8d3a-7c23603788ac
PRODUCT NDC: 0310-1969
APPLICATION NUMBER: NDA204760

Other NALOXEGOL OXALATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AstraZeneca Pharmaceuticals LPMOVANTIK
Avera McKennan HospitalMOVANTIK
Lake Erie Medical DBA Quality Care Products LLCMOVANTIK